$14.410
+0.285 (+1.98%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de NPCE por análisis de gráficos similares
Alphio's NPCE stock price prediction model matches the current Neuropace Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $14.29 (-0.84%). The 1-week path is $14.41 (-0.01%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Neuropace Inc?
Neuropace Inc is a good buy right now due to its current price of $14.41 being significantly below analyst targets, with Mizuho projecting a price of $22, indicating a potential upside of over 52%. Additionally, the company's gross margin has improved to 82.83% in Q2 2026, showcasing strong profitability potential. However, the main risk is the FDA denial for the RNS system expansion, which could impact revenue growth projections, particularly as the company anticipates a revenue range of $99 million to $101 million for 2026, which could be affected by this setback.
NPCE cerró en $14.41 el Friday, tras subir +1.98%
Neuropace Inc (NPCE) last closed at $14.41, gaining +1.98%. These facts feed the 1-day and 1-week NPCE price prediction above.
Factores de la previsión
Los factores de la previsión de Neuropace Inc (NPCE) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de NPCE, ordenadas por similitud.
Análisis de estacionalidad de NPCE
Historically the probability of a positive August return for NPCE is 0.00%. December offers the highest probability of a positive month at 100.00%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de NPCE
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $15.07 | $17.43 | $19.34 | +20.98% |
| Sep 2026 | $17.17 | $17.54 | $21.22 | +21.72% |
| Oct 2026 | $14.20 | $14.75 | $18.13 | +2.38% |
| Nov 2026 | $10.20 | $12.85 | $16.25 | -10.83% |
| Dec 2026 | $16.30 | $17.12 | $19.11 | +18.78% |
En 2026, se proyecta que Neuropace Inc (NPCE) oscile entre $10.20 y $21.22.
Previsión mensual de Neuropace Inc para 2026
En Aug de 2026, se proyecta que Neuropace Inc promedie $17.43, con un mínimo de $15.07 y un máximo de $19.34.
En Sep de 2026, se proyecta que Neuropace Inc promedie $17.54, con un mínimo de $17.17 y un máximo de $21.22.
En Oct de 2026, se proyecta que Neuropace Inc promedie $14.75, con un mínimo de $14.20 y un máximo de $18.13.
En Nov de 2026, se proyecta que Neuropace Inc promedie $12.85, con un mínimo de $10.20 y un máximo de $16.25.
En Dec de 2026, se proyecta que Neuropace Inc promedie $17.12, con un mínimo de $16.30 y un máximo de $19.11.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.